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ABSTRACT
The entire chicken lysozyme gene locus including all
known cis-regulatory sequences and the 5' and 3'
matrix attachment sites defining the borders of the
DNase I sensitive chromatin domain, is expressed at
a high level and independent of its chromosomal
position in macrophages of transgenic mice. It was
concluded that the lysozyme gene locus carries a locus
control function. We analysed several cis-regulatory
deletion mutants to investigate their influence on tissue
specificity and level of expression. Position
independent expression of the gene is lost whenever
one of the upstream tissue specific enhancer regions
is deleted, although tissue specific expression is
usually retained. Deletion of the domain border
fragments has no influence on copy number
dependency of expression. However, without these
regions an increased incidence of ectopic expression
is observed. This suggests that the domain border
fragments may help to suppress transgene expression
in inappropriate tissues. We conclude, that position
independent expression of the lysozyme gene is not
controlled by a single specific region of the locus but
is the result of the concerted action of several tissue
specific upstream regulatory DNA elements with the
promoter.
INTRODUCTION
Transcriptional activation of a gene locus leads to distinct changes
in the structure of the surrounding chromatin. Active genes or
gene clusters are located within regions of general DNase I
sensitivity, which are not restricted to the coding region, but
extend into 5' and 3' flanking chromatin (1-3). Active cis-
regulatory elements usually located within the domain of general
DNase I sensitivity adopt a distinct non-nucleosomal
conformation, which renders them hypersensitive with respect
to DNase I digestion [For review: (4)]. It is not known whether
chromatin decondensation is autonomous and has to preceed the
transcriptional activation of a gene, or whether the general
DNase I sensitivity of active gene loci is the consequence of a
topological constraint on the chromatin as a result of transcription
itself (5). The first model would imply a hierarchy of cis-
regulatory DNA elements some of which would function as
master switches responsible for the initial, differentiation
dependent commitment of a gene locus towards gene expression.
Evidence for these type of regulatory elements comes from
experiments describing the features of DNA elements having a
dominant control function in the activation of gene expression,
the locus control regions (LCRs). LCRs were first described in
the human 3-globin gene cluster (6,7) and have been detected
in a variety of developmentally regulated genes (8- 15). LCRs
have transcriptional enhancer activity, are necessary for high
level, tissue specific expression and direct transcription
independent of the random chromosomal position of integrated
transgenes (6,16). They are often associated with developmentally
stable DNase I hypersensitive chromatin sites (DHSs), which are
present before specific mRNA can be detected (7,17,18). In the
human 3-globin system the formation of DNase I sensitive
chromatin is dependent on the presence of at least parts of the
LCR (19). However, chromatin analysis of deletion mutants of
the chicken 3-globin locus in transgenic mice indicate the
dependence of the establishment of generally DNase I sensitive
chromatin on the presence of both the enhancer/LCR and the
promoter (20).
The chicken lysozyme gene, one of the major egg white protein
genes is expressed in the oviduct. The same gene is also expressed
in the myeloid lineage of the hematopoietic system. Expression
is gradually switched on during macrophage differentiation,
reaching its highest level in the mature, activated macrophage
(21,22). Lysozyme gene transcription is regulated by a complex
set of cis-regulatory DNA elements consisting of several tissue
specific enhancers, a silencer and promoter elements (21-25).
The activity of these cis acting elements is marked by tissue
specific DHSs (26-28). The active gene locus including all cis
acting elements is located within a domain of general DNase I
sensitivity, which spans 24 kb (2). The DNase I sensitive domain
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is flanked by DNA sequences which have a high affinity for the
nuclear matrix in vitro (29). The domain border fragment
containing the 5' matrix attachment region was shown to be able
to stimulate transcription in stable transfections and to buffer
linked reporter genes from chromosomal position effects (30,31).
When the complete chicken lysozyme locus is introduced into
the germline of mice it is expressed as a macrophage specific,
independent regulatory unit regardless of its random position in
the host genome (32). We therefore conclude, that this DNA
construct contains the locus control function of this gene.
Two regions within the lysozyme locus outside the immediate
promoter area carry well characterized macrophage specific
enhancers and could serve as candidates for a LCR. One enhancer
is located 2.7 kb, the second one 6.1 kb upstream of the
transcription start (23,33,34). The activity of both enhancers is
marked by the presence of a DHS in the chromatin of macrophage
cells. The DHS at the -6.1 kb enhancer is present in all active
or potentially active cell types (oviduct, all retrovirally
transformed macrophage precursor cell lines and primary
macrophages) regardless of the level of lysozyme mRNA (22,27).
In contrast, the DHS at the -2.7 kb enhancer appears only in
cells representing late stages of macrophage differentiation where
the transcriptional activity of the lysozyme gene is high. It is not
present in the oviduct (24,27). These results suggested a
differential temporal regulation of the activity of the two
enhancers during development (22). Transfection assays have
shown both enhancers to be tissue specifically active in myeloid
cells (21,23,33,34). However, from these experiments it could
not be decided whether the activation of the lysozyme locus during
development can be mediated by the independent action of both
enhancers or whether the activiation of the -2.7 kb enhancer
and the subsequent activation of lysozyme gene expression is
dependent on the previous function of the -6.1 kb enhancer.
It is also not known whether position independent expression can
be assigned to one or several cis acting elements.
In this report, we describe the role of these two regulatory
regions and the domain border fragments with respect to the
activation of the chicken lysozyme gene domain in macrophages
of transgenic mice. We show that both enhancer regions do not
act in a hierarchical order since they can individually activate
the lysozyme gene in a tissue specific manner. In the presence
of the complete set of regulatory sequences deletion of the domain
border fragments has no consequences on macrophage specificity
and copy number dependency of transgene expression. However,
absence of the domain border fragments in constructs carrying
incomplete regulatory units results in a higher incidence of ectopic
expression. Copy number dependency of expression can not be
assigned to a single regulatory element. Only the presence of
the complete set of cis-regulatory sequences ensures position
independency of transgene expression at random chromosomal
positions.
MATERIALS AND METHODS
Construction of deletion mutants of the chicken lysozyme
domain
All constructs and their subsequent injected fragments were
derived from plasmid polUlilys (32). The XbaI-SmaI XS
fragment was purified from a polyIIIilys plasmid in which the
second XbaI site located in the second intron was inactivated
(pfIhilys-X2). The Xba' (X') site shown in Figure IA is not
cleaved in procaryotic DNA due to an overlapping dam-
methylation sequence. The KS fragment was purified from
polyHIilys digested with KpnI and SnaI. The dXK construct was
prepared by ligating the 3 kb B-1X1 fragment (30) carrying the
5' matrix attachment sites into polylli K1X4 (32) cut with
Asp718. The dSS construct was prepared as follows: The 1.6
kb fragment reaching from Sacd site [S4; (35) at -900 to the
BamHI site at + 700 (B3)] was ligated into plasmid polyHIi
(pIHiS4B3) followed by the ligation of the 5.0 kb BamHI
fragment reaching from BamHI site 3 to BamHI site 4 which
carries the rest of the coding region and the poly A addition point
into the BamHI site of plIIiS4B3. This construct was named
plIilysS4B4. plIEilysS4B4 was then digested with EcoRV which
cuts in the polylinker of the vector immediately upstream of the
S4 site and with SpeI which cuts at +2600 in the second intron.
The 3.5 kb EcoRV -SpeI fragment was ligated into polyililys
digested with SpeI which cleaves at -3000 and at +2600. The
injected dSS and dXK fragments were liberated from the vector
by digestion with XhoI. The injected XSdSS fragment was
generated from the dSS construct by digestion with XbaI and
SmaI.
Generation and characterization of transgenic mice
The fragments carrying different parts of the chicken lysozyme
gene domain were purified from vector sequences as described
(36) and injected into fertilized oocytes from CBAxC57 bl mice
(37). Transgenic mice were identified by PCR analysis of tail
DNA using chicken lysozyme specific primers and Southern
blotting. Copy numbers of integrated transgenes were determined
by phosphorimager analysis of genomic Southern blots from
EcoRI digested genomic DNA hybridized simultaneously with
a lysozyme specific probe recognizing a 2.7 kb EcoRI fragment
located in the 3' half of the gene (35) and a Thyl probe (6)
recognizing the endogenous mouse gene to control loading
differences. Single copy mice in the KS-series were identified
by cleavage of tail DNA with BamH1, which cuts only once in
the integrated fragment. EcoRI digested plasmid poly]IIilys or
chicken genomic DNA were used as a standard for the calculation
of actual copy numbers. In order to eliminate founder mice
chimeric for the injected gene, DNA from liver, spleen, brain
and kidney was tested for the copy number of the lysozyme
transgene by Southern blotting. Most other mouse lines were bred
before expression analysis to generate Fl generations if not
otherwise indicated. Mouse lines Oa and Ob were generated from
one founder mouse carrying two different nonlinked transgene
clusters which could be bred into two lines carrying one
integration site respectively, as demonstrated by Southern blot
analysis of end fragments. Homozygous mouse line 4 (32) carries
100 copies of the complete wild type (wt) lysozyme gene domain.
RNA preparation and Si protection analysis
RNA from various tissues of at least six week old mice were
prepared with LiCl/urea (38). RNA from cultured chicken cells
and from primary mouse macrophages was prepared by the acid
guanidinium thiocyanate-phenol-chloroform extraction method
(39). A 530 bp BstNI fragment spanning the promoter region
served as a chicken lysozyme specific S1 hybridization probe
(21), a 320 bp BamHI -AvaI fragment from pHF(3A- 1 (40) was
used as a j-actin specific probe. S1 analysis for chicken lysozyme
and ,3-actin mRNA was performed as described (32). To construct
a mouse lysozyme hybridization probe a 320 bp EcoRI-PstI
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fragment of plasmid pmLcl carrying the mouse lysozyme M
cDNA (41), containing exons 1 and 2 was cloned into Bluescribe
(M13+) and named pmLc2. A 315 bp BstNI fragment isolated
from pmLc2 containing vector sequences provided a mouse
lysozyme specific internal hybrilization probe. Hybridization with
this probe was performed at 50°C overnight and digestion with
100 units Si nuclease was performed for 1.5 h at 37°C. Si
resistant fragments were run on a 7.5% polyacrylamide/urea gel.
SI hybridization signals were quantified by phosphorimager
analysis. To determine the expression levels per gene copy SI
hybridization signals for ,B-actin and chicken lysozyme were
quantified. The chicken lysozyme expression value was then
calibrated with respect to the 3-actin specific signal. To prove
that the calculated expression level per gene copy in XS mice
was correct, an SI hybridization assay was performed in which
RNA samples from transgenic mouse macrophages were diluted
with macrophage RNA from nontransgenic mice to contain the
same amount of specific RNA as determined in the previous assay
and the same amount of total RNA. The first SI hybridization
assay containing the same amount of transgenic mouse
macrophage RNA was then repeated.
Cell cultures
HD1l cells (42) were grown in standard Iscove's medium
supplemented with 8% fetal calf serum and 2% chicken serum.
Mouse L-cell fibroblasts used to prepare conditioned medium
were grown in Iscove's medium, 10% fetal calf serum. Primary
mouse macrophages were prepared by peritoneal flush 4 days
after injection of 3% Thioglycolate medium (Gibco) in PBS into
the peritoneal cavity of transgenic mice. Cells were cultured
overnight in Iscove's medium plus 10% L-cell conditioned
medium (32).
RESULTS
The generation of transgenic mouse lines carrying deletion
mutants within the chicken lysozyme gene domain
We generated a series of transgenic mice carrying constructs in
which one or several DNA elements of the complete lysozyme
gene domain were deleted (Figure IA). Two constructs carry
internal deletions. In one of them a 3.4 kb fragment containing
the early -6.1 enhancer was removed (dXK). In addition this
fragment included DNA sequences with no apparent cis-
regulatory function adopting a constitutive DHS at -7.9 kb in
the chromatin of all cell types investigated to date. In the other
construct a 2 kb fragment carrying three cis-regulatory elements
including the -2.7 kb enhancer (dSS) was deleted. The latter
deletion in addition removes the silencer element at -2.4 kb (43)
and the steroid responsive element necessary for expression of
the gene in the oviduct (44). The DHSs marking the activity of
the silencer is present in macrophage progenitor cells, non
expressing cells and the oviduct (27). Its disappearance parallels
the appearance of the -2.7 kb DHS during macrophage
maturation (22). In mature primary macrophages only the -2.7
kb DHS is present and the -2.4 kb DHS is absent (27,28). In
another series of constructs carrying either the complete set of
cis acting elements or internal deletions as described above the
5' and 3' domain border fragments were removed (XS, KS,
XSdSS). The 3' domain border fragment carries a DHS, which
is only present in oviduct and non-expressing cells, but absent
in macrophages (27).
For each construct between 4 and 12 different mouse lines were
generated (Figure 1B). Copy number and integrity of the
integrated transgenes was investigated by Southern blotting. No
evidence for rearrangements within the integrated gene clusters
was found (data not shown). The variation in copy numbers of
integrated transgenes in the different mouse lines appeared to be
random and independent of the type of insert (Table 1). Most
founder mice were bred for the analysis of the F1 generation
to avoid quantitation mistakes due to mosaicism. Founder mice
used in this analysis were examined carefully to be non-mosaic
(see Methods).
Each enhancer region can direct chicken lysozyme transgene
expression into macrophages
The wild type construct (wt, Figure IA) is exclusively expressed
in macrophages, spleen and in the brain. Brain expression is
specific and is found in the same cell tpe in several independently
investigated transgenic mouse lines (45). Expression in spleen
is due to the presence of macrophages in this organ (32,45).
Within the limits of the assay, expression could not be found
in any other cell type (Figure 1B). Without the upstream region
harboring the early -6.1 kb enhancer (dXK) macrophage specific
lysozyme expression is observed in three of five mouse lines
(Figure 2A, mice 0, 2, 6 with 2, 13 and 13 gene copies,
respectively). One mouse line did not express the gene in any
tissue (mouse 9 with 8 gene copies) and one mouse line expressed
the gene at approximately the same level in four different tissues
including macrophages (Figure 2A, mouse 25 with 43 gene
copies). In all mouse lines brain expression was below the level
of detection. Without the intermediate region carrying the -2.7
kb enhancer/-2.4 kb silencer region (dSS) transgene expression
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Figure 1. (A) Map of the chicken lysozyme locus (upper part) and of the injected
DNA fragments (lower part). The intron -exon structure and the coding region
are indicated by black vertical bars, the major transcription start is indicated by
an arrow. The positions of DNase I hypersensitive chromatin sites (DHS) are
indicated by arrows above the map. The domain border fragments harboring matrix
attachments regions are indicated by the line with the hook. The position of
restriction sites are indicated above and below the map. X: XbaI, (X): XbaI site
which has been removed in some of the injected fragments, X': XbaI site which
is not cleaved in procaryotic DNA, K: KpnI, Sp: SpeI, Sa: Sacl, S: SmaI, Xh:
XhoI. wt: mouse lines described in (32). (B) Summary of the results presented
in this paper. WT expression pattern refers to expression observed in macrophages
only or macrophages and brain as observed with the wild type construct, nonspecific
expression refers to expression in other tissues. In some cases the wild type pattern
and additional nonspecific expression is observed. Expression in lung is regarded
as nonspecific. Mouse lines not listed in the table do not express the transgene
in any tissue. var: variable levels per gene copy in different transgenic lines.
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Table 1. Expression of deletion mutants within the lysozyme gene domain in transgenic mice
construct mouse lysozyme mRNA .-actln mRNA lysozyme mRNA level copy number c normalized lysozyme
line levels in macrophages levels in macrophages In macophages mRNA level
(arbitrary units) a (arbitrary units) a (normalized values) b per transgene copy(+/- 30%)
UT 4d 41825 11112 41825 100 418
25 2757 69729 439 43 10
2 67066 31641 23552 13 1811dXK6e 25052 42474 6554 13 0
ge 0 63979 0 8 0
0 14066 45041 3470 2 1735
4 1442 55984 286 35 8
18 614 20416 334 34 10
da 34 43215 30231 15884 24 6617 17255 23268 8233 13 633
8 5546 25543 2412 11 219
15 1424 56684 279 10 3
12 307 19944 171 8 21
Ob 198600 23820 92646 74 1251
13 46951 12660 42488 15 2832
XS 15e 45852 17892 28476 10 2847
Oa 49596 16488 33424 9 3713
N 44316 25752 19122 7 2731
Clle 0 13561 0 63 0
A5e 29606 19133 17194 54 318
C13e 7608 23972 3526 38 92
B2e 0 8850 0 15 0
KS B5e 0 33872 0 8 0
Cle 0 32852 0 4 0
C3e 1 241 14580 945 3 315
Boe 7608 11970 7062 2 3531
C6e 0 26678 0 2 0
A13e 9837 14103 7750 1 7750
Ble 923 20661 496 1 496
Aoe 0 24003 0 1 0
26 809 15282 588 138 4
XSdss 5 8875 24998 3945 71 550 3088 28278 1213 46 26
28 59328 22325 29529 16 1845
aExpression levels were quantified by phosphorimager analysis.
bLysozyme expression levels were normalized with respect to WT 3-actin expression levels. The expression levels per gene copy in XS mice
were determined by repeated Sl analysis as described in Methods.
Ccopy numbers were determined by quantitive Southern blotting.
dBonifer et al., 1990.
eFounder mice were analyzed.
could be detected in macrophages of all mouse lines. All mice
except mouse 12 showed a significant level of brain expression
(see also Figure 5). Expression in macrophages of four of seven
mouse lines was higher than in brain (Figure 2B, mice 34, 7,
8, 18 with 35, 13, 11 and 34 gene copies, respectively), in two
mouse lines it was lower (Figure 2B, mice 15 and 4 with 10 and
35 gene copies; see also Figure 5A and Table 1) and one mouse
expressed the transgene at a very low level (Figure 2B, mouse
12 with 8 gene copies; see also Table 1). No lysozyme mRNA
was found in any other tissue. Taken together, we conclude that
deletion of either enhancer region from the chicken lysozyme
domain does not disable transgene expression in macrophages.
The presence of the complete set of cis-regulatory sequences
results in high level and macrophage specific expression
Lysozyme DNA constructs carrying two copies of the 5' matrix
attachment region flanking the -6.1 kb enhancer, the lysozyme
promoter and the CAT reporter gene have in previous
experiments been stably transfected into chicken promacrophage
cells. They were expressed in a position independent manner with
an exponential relationship between copy number and expression
level. This result led to the hypothesis that the border elements
buffer the chromatin mediated position effect usually observed
after stable transfection (30). We were interested to examine the
role of the domain border fragments in the context of the whole
lysozyme gene domain in the more stringent transgenic mouse
system.
The first construct we examined (XS) lacked the domain border
fragments, but still carried all cis-regulatory sequences. All five
different mouse lines carrying this construct expressed the
transgene at a high level in macrophages (Figure 3). The
expression pattern was very similar to that observed in mice
carrying the wild type construct (32). In addition, lysozyme
expression levels followed transgene copy numbers (Table 1, see
below). Two mouse lines showed a low level of chicken lysozyme
expression in thymus and lung (Figure 3, mice Oa and Ob with
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Figure 2. (A) Expression of the dXK construct in transgenic mouse tissues. RNA was prepared from liver (L), heart (H), kidney (K), lung (Lg), spleen (S), brain
(B), thymus (T) and macrophages (MO). 7 Ag of RNA were subjected to SI hybridization analysis with a chicken lysozyme specific probe (upper panel) or a 3-actin
probe (lower panel). SI nuclease resistant fragments were analyzed on a 7.5% polyacrylamide/urea gel. + 1/-2, -24 and -58 bp refer to the three main transcriptional
start sites on the lysozyme promoter (47). (B) Expression of the dSS construct in transgenic mouse tissues. 7 pAg of RNA prepared from various mouse tissues were
examined by SI hybridization analysis as described in the legend of Figure 2. (-): no RNA. For copy numbers and nomenclature see Table 1.
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Figure 3. Expression of the XS construct in transgenic mouse tissues. 7 pg RNA prepared from different mouse tissues as described in the legend of Figure 2 were
analyzed in the Si protection assay with probes specific for chicken lysozyme and ,B-actin (upper panels), as well as for mouse lysozyme (m-lys; lower panel). 0
= oviduct. wt refers to a mouse line carrying 100 copies of the wild type construct, 0 refers to an offspring of the original founder still carrying both transgene
integration loci before breeding into lines Oa and Ob. (B) Expression of the KS construct in transgenic mouse tissues. 7 pg RNA prepared from various mouse tissues
were subjected to an S1 analysis as described in the legend of Figure 2. (+): RNA prepared from macrophages of mice carrying the wild type construct. For copy
numbers and nomenclature see Table 1.
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Figure 4. Expression of the XSdSS construct in transgenic mouse tissues. 7 Ag RNA prepared from various mouse tissues were subjected to an SI analysis as described
in the legend of Figure 2. For copy numbers and nomenclature see Table 1.
9 and 74 gene copies, respectively). For comparison we measured
endogenous mouse lysozyme expression in the different tissues
of three different transgenic mouse lines (Figure 3, lower panel).
Each of them showed a significant amount of endogenous mouse
lysozyme mRNA in lung and spleen, as it has been seen before
(41,46). However, we were unable to detect lysozyme mRNA
in lungs of mice carrying the wild type construct, therefore we
regard expression of the transgene in the lung as nonspecific.
No differences in transgene expression could be found between
individual members of each line (data not shown). It is obvious
that deletion of the domain border fragments has no effect on
the expression of the transgene in macrophages.
Incomplete regulatory units without domain border fragments
show an increased incidence of nonspecific expression
The next constructs we investigated lacked the domain border
fragments and carried only one of the enhancer regions. The first
construct (KS) contained only the -2.7 kb enhancer region. The
analysis of transgene mRNA levels in various tissues of 12
founder mice showed, that half of the mice did not express the
transgene at all. Most of the remaining mice showed low
transgene expression levels in macrophages (Figure 4A).
Furthermore, we found lysozyme mRNA to be expressed
ectopically. One mouse (Figure 4A, mouse A5 with 54 gene
copies) expressed the gene at different levels in thymus, spleen
and lung but at a low level in macrophages. In four other mice
lysozyme mRNA was found in the liver (Figure 4A, mice B2
and C6 with 15 and 2 gene copies, respectively) or in the lung
(Figure 4A, mice A13 and BO with 1 and 2 gene copies,
respectively). One mouse (C13 with 38 gene copies) expressed
the gene at a very low level in all tissues analyzed (data not
shown). Transgenic mice carrying a construct with only the -6.1
kb region (XSdSS) showed a similar expression pattern as mice
carrying the dSS construct (Figure 4B). Expression in the brain
could be observed in all mice including mouse 26 (a specific
signal was visible after longer exposure of the film, data not
shown). One mouse, however, expressed a very high level of
lysozyme mRNA in the lung (Figure 4B, mouse 28). In lung
cells the three lysozyme specific transcriptional start sites at the
promoter are not used with the same relative frequency as in
macrophage cells. Only the +1/-2 and the -24 start sites are
used, whereas macrophages use an additional start at -58 (47).
With both constructs a significantly increased incidence of
nonspecific expression is observed when compared to mice
carrying the same cis-regulatory elements plus the domain border
fragments. Only 1 out of 11 expressing dXK and dSS mice
expressed the lysozyme transgene ectopically, whereas this is the
case for 7 out of 10 expressing KS and XSdSS mice (Figure 1B).
Position independency of expression is a result of the
cooperation of all cis-regulatory elements within the chicken
lysozyme gene domain
One of the key defmiitions of locus control regions is their ability
to direct copy number dependent expression of transgenes
irrespective of their random position of integration into host
chromatin. We examined the precise transgene expression level
in macrophages (Figure 5A) and determined the expression levels
per gene copy (Table 1). All chicken lysozyme expression values
were calibrated with respect to ,-actin mRNA levels in order
to compare absolute expression levels (Table 1). The average
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Figure 5. (A) Comparison of the chicken lysozyme expression level in
macrophages of different mouse lines carrying the various constructs. For
nomenclature see Table 1. Macrophage RNA was subjected to SI protection
analysis as described. KS, dXK: 7 14g RNA, dSS, XSdSS: 3.5 Ag RNA, XS:
1.5 jig RNA, respectively. RNA prepared from macrophages carrying the wt
construct served as standard. wt control in XS, dSS and XSdSS: 0.5 izg, 1.75
jAg and 3.5 1ig RNA, respectively. 15 jig (1) and 30 jig (2) HD 11I RNA served
as an additional standard (Panel KS and dSS). The gels were exposed to a Kodak
XAR film with an intensifier screen at -70'C. Exposure times was adjusted
with respect to the wt standard. (B) Comparison of the chicken lysozyme expression
level in brains of mice carrying the dSS construct. For nomenclature see Table
1. 7 jig RNA was subjected to SI hybridization analysis as described.
expression level per gene copy for each of the constructs lacking
one enhancer region (KS, XSdSS, dXK, dSS) is very low. All
28 mouse lines carrying these constructs show highly variable
levels of transgene expression in macrophages indicating the
influence of strong chromosomal position effects. The only
exception, in addition to the previously shown wt construct (32),
is construct XS which also carries all cis-regulatory DNA
elements. Expression levels in macrophages of XS mice are
consistently higher in macrophages than in any other tissue
(Figure 3) and follow transgene copy number. The expression
level per gene copy is similar for all five individuai lines.
Brain expression in mice carrying the wild type construct was
copy number dependent and thus independent of the genomic
position (32). To investigate the role of the different cis-regulatory
regions in the brain, we took advantage of the mouse lines
carrying the dSS construct which express the chicken lysozyme
transgene in macrophages and brain. In macrophages transcription
of the transgene shows the usual microheterogeneity of start sites
at the promoter, exactly as it is found for the endogenous gene
in the chicken (47). However, ftranscription in the brain did mostly
start from the + 1/-2 start site, indicating a different mode of
transcriptional initiation in brain as compared to macrophages
(Figure 2B). Transgene expression levels in the brain did not
follow transgene copy numbers (Figure 5B).- The comparison of
brain and macrophage expression levels in the same transgenic
animal showed that high expression in macrophages does not
parallel high expression in the brain (Figure 4B), despite the fact
that in the two different tissues the same construct is integrated
at the same chromosomal position.
DISCUSSION
The anatomy of the locus control function located on the
lysozyme gene domain
Extensive structural and functional studies have revealed a
surprisingly complex set of cis-regulatory DNA elements involved
in the control of the tissue specific activation of the lysozyme
gene locus in oviduct and in macrophages [for review: (24,25)].
In the analysis described here we focused on two regions
containing the -6.1 kb enhancer and the -2.7 kb enhancer which
are the main myeloid specific stimulatory elements located within
the lysozyme gene domain. The anatomy of both enhancers was
extensively characterized. The -6.1 kb enhancer core is
composed of seven different modules harboring binding sites for
the NFI, API, C/EBP transcription factor families and two
unknown proteins (23). The -2.7 kb enhancer has a less complex
structure, it consists of binding sites for proteins of the ets-, API-,
and C/EBP-transcription factor families (48,49). The experiments
described in this paper show the contribution of each regulatory
region to correct transgene regulation:
In ten of twelve mouse lines macrophage specific expression
of the transgene can be achieved with constructs flanked by the
domain border fragments and containing only one of the two
enhancer regions. However, the two enhancer regions have
different capabilities, which is most apparent in constructs lacking
the domain border fragments. In that case the -6.1 kb enhancer
region can still direct macrophage specific expression. The -2.7
kb region is unable to do so, which may be the result of its less
complex modular structure or its different temporal regulation.
The finding that neither enhancer region is capable of directing
position independent expression on its own differs from results
obtained with subregions of the 03-globin LCR. Such elements
can direct position independent gene expression, albeit at lower
level (50) and only when the gene constructs are present in
multiple copies (51), suggesting that j3-globin LCR subregions
in contrast to the lysozyme elements are able to interact with
themselves to provide LCR activity.
Lysozyme constructs containing the domain border fragments
but only one enhancer region were not expressed in a copy
number dependent way. Hence, the domain border fragments
are not sufficient to insulate a gene lacking one essential cis-
regulatory element from position effects in lysozyme expressing
cells. However, mice carrying the same deletions but lacking the
domain border fragments show a significantly higher incidence
of ectopic transgene expression (7 of 10 expressing KS and
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XSdSS mice) than those with border fragments present (1 of 11
expressing dXK and dSS mice). This result indicate that the
domain border fragments help to suppress ectopic transgene
activation by random neighbouring cis acting elements. It would
be premature to make any suggestions about the molecular nature
of this insulating function on the basis of the present results. It
is also difficult to compare the buffering effect of the two domain
border fragments with the position effect buffering activity of
the 5' domain border fragment observed in stably transfected
retrovirally transformed promacrophage cells in culture (30). The
transfected constructs were artificial combinations of lysozyme
regulatory sequences and the CAT reporter gene. In transgenic
mice we analyzed constructs of a more complex nature which,
with the exception of the deletions, have the correct spatial
arrangement of regulatory sequences. Secondly, retrovirally
transformed monocytes reflect only one differentiation status of
the myeloid lineage and DNA transfected into cultured cells will
most likely integrate into active chromatin regions. In the
transgenic mouse the DNA is integrated at an early stage where
transcription is absent (52) and without selection for chromatin
regions active in myeloid cells. During development integrated
DNA constructs have to be able to reorganize chromatin
structure, to activate transcription in the right cell type and to
suppress activation in all other cells. Constructs which are
expressed correctly in transfected cultured cells might therefore
not fulfil all demands of the more stringent transgenic animal
system.
The concerted action model for the correct function of
transgene promoters
The DHS pattern of the early -6.1 kb enhancer and the late -2.7
kb enhancer in various chicken cells suggested a stepwise
activation of the gene locus during macrophage differentiation
(22). It was therefore speculated, that the -6.1 kb enhancer and
not the -2.7 kb enhancer could act as a dominant control element
(25) and by that being a prerequisite for the activation of the later
acting cis-regulatory elements. The experiments described in this
paper show, however, that if flanked by domain border fragments
each individual enhancer region is by itself capable of activating
lysozyme transcription in macrophage cells. The activity of one
enhancer is not dependent on the previous function of the other,
instead they cooperate.
We conclude that only the concerted action of all regulatory
elements of a gene locus leads to a correct developmental
regulation of a transgene. It is, therefore , no surprise that the
transfer of transgenes on yeast artificial chromosomes (YACs)
into the mouse germ line results in a correct regulation of
transgenes (53,54). Due to their large size YACs will usually
include the complete regulatory domains of gene loci even when
their structural and functional extensions are not yet determined.
Most likely the regulatory protein complex at the promoter
requires a saturating amount of interacting transcription factors
bound to other cis-regulatory elements provided by a complete
gene locus, otherwise deregulating position effects become
apparent. Support for this interpretation comes from experiments
examining the chromatin structure of the different lysozyme
transgenes in mouse macrophages. In macrophage nuclei of all
mouse lines carrying position independently expressed transgenes
all DHSs indicating the activity of cis-regulatory elements are
formed in the chromatin of all transgene copies. This is not the
case in mouse lines carrying transgenes with position dependent
expression (55). Currently we examine the interaction of each
individual cis-regulatory element with the promoter region in
order to define their exact role in the tissue and stage specific
transcriptional activation of the lysozyme locus in transgenic
mice.
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